# 气道肺支架市场

> 气道肺支架市场研究报告，按支架材料（镍钛合金、硅胶、聚氨酯、聚四氟乙烯（PTFE）、不锈钢）、按支架设计（单法兰支架、双法兰支架、Palmaz-Schatz支架、Wallstents、Cavitron Ultra支架）、按支架功能（支气管支架、气管支架、食道支架）、按输送方式（刚性支气管镜、柔性支气管镜、气管切开）以及按地区（北美、欧洲、南美、亚太、中东和非洲）- 预测到2035年

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.44%
- **2024:** $ 5.84 Billion
- **2025:** $ 6.16 Billion
- **2035:** $ 10.46 Billion
- **Key Players:** Boston Scientific (US), Medtronic (US), Cook Medical (US), Bard Peripheral Vascular (US), Halyard Health (US), Teleflex (US), Conmed (US), Olympus Corporation (JP), Stryker Corporation (US)

**Report ID:** MRFR/HC/7389-HCR · **Pages:** 100 · **Author:** Satyendra Maurya & Rahul Gotadki · **Last Updated:** April 15, 2026

**URL:** https://www.marketresearchfuture.com/reports/airway-lung-stent-market-8861

---

## Market Summary

## **Airway Lung Stent Market Overview:**

As per MRFR analysis, the Airway Lung Stent Market Size was estimated at 5.84 (USD Billion) in 2024. The Airway Lung Stent Market Industry is expected to grow from 6.16 (USD Billion) in 2025 to 9.92 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 5.44% during the forecast period (2025 - 2034).

### **Key Airway Lung Stent Market Trends Highlighted**

Advancements in medical technology are driving the growth of the airway lung stent market. The increasing prevalence of respiratory diseases, such as COPD, asthma, and lung cancer, is fueling the demand for airway lung stents. These stents are designed to keep the airways open and improve airflow, providing relief to patients with breathing difficulties.

Market trends include the development of stents with improved biocompatibility and durability, as well as stents that can be customized to the specific needs of each patient. Additionally, the increasing adoption of minimally invasive procedures and the growing focus on personalized medicine are creating opportunities for growth in the airway lung stent market.

Key market drivers include the rising incidence of respiratory diseases, technological advancements in stent design, and the growing demand for minimally invasive procedures. New opportunities lie in the development of stents that can be used in conjunction with other treatments, such as drug delivery, and the expansion of the market into developing regions.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Airway Lung Stent Market Drivers**

### **Increasing Prevalence of Chronic Respiratory Diseases**

Chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and asthma, are major contributors to the rising demand for airway lung stents. COPD is a progressive lung disease that causes airflow blockage and shortness of breath.

Asthma is a chronic inflammatory condition that affects the airways and can cause wheezing, coughing, and chest tightness. As the prevalence of these diseases continues to rise, so will the demand for effective treatment options, including airway lung stents.

### **Technological Advancements and New Product Development**

The Airway Lung Stent Market is constantly evolving, with new technologies and products being developed to meet the changing needs of patients and healthcare providers.

For instance, recent advancements in materials science have led to the development of stents that are more flexible, durable, and biocompatible. These new stents are less likely to cause complications and can be used to treat a wider range of patients.

### **Growing Awareness and Acceptance of Airway Lung Stents**

As the benefits of airway lung stents become more widely recognized, their acceptance among both patients and healthcare providers is increasing.

Patients are becoming more aware of the potential benefits of stents, such as improved breathing and reduced symptoms.

Healthcare providers are also becoming more comfortable with the use of stents, as they gain experience with the procedure and see the positive outcomes that can be achieved.

## **Airway Lung Stent Market Segment Insights:**

### **Airway Lung Stent Market Stent Material Insights **

The Airway Lung Stent Market is segmented based on stent material into Nitinol, Silicone, Polyurethane, Polytetrafluoroethylene (PTFE), and Stainless Steel. Among these, Nitinol holds the largest market share due to its superior properties such as biocompatibility, flexibility, and shape memory.

Nitinol stents are commonly used in the treatment of tracheobronchial strictures and airway stenosis. Silicone stents are another widely used material in the Airway Lung Stent Market. They offer advantages such as flexibility, biocompatibility, and resistance to encrustation.

Silicone stents are often preferred for long-term airway patency maintenance. Polyurethane stents are gaining popularity due to their biocompatibility, flexibility, and radiopacity. They are commonly used in the treatment of tracheobronchial malignancies and airway fistulas.

Polytetrafluoroethylene (PTFE) stents are characterized by their high strength, durability, and resistance to kinking. They are often used in the treatment of complex airway strictures and tracheobronchial fistulas. Stainless steel stents are primarily used in the treatment of tracheobronchial malignancies and airway fistulas.

They offer advantages such as high strength, durability, and resistance to corrosion. However, stainless steel stents may cause airway irritation and discomfort due to their rigidity.

The Airway Lung Stent Market is expected to witness significant growth in the coming years, driven by the increasing prevalence of respiratory diseases, technological advancements, and rising healthcare expenditure.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Airway Lung Stent Market Stent Design Insights**

The Airway Lung Stent Market is segmented by Stent Design into Single-Flanged Stents, Double-Flanged Stents, Palmaz-Schatz Stents, Wallstents, and Cavitron Ultra Stents. Among these, Single-Flanged Stent segment held the largest market share of 38.4% in 2023 and is expected to continue its dominance during the forecast period.

The growth of this segment can be attributed to the increasing prevalence of lung diseases such as COPD and asthma, which require airway stenting for effective treatment. Double-Flanged Stents accounted for a significant market share of 29.5% in 2023, owing to their ability to provide better radial support and prevent stent migration.

Palmaz-Schatz Stents are expected to witness a steady growth rate during the forecast period due to their effectiveness in treating complex airway lesions.

Wallstents and Cavitron Ultra Stents are relatively newer technologies and are gaining popularity due to their advanced features and improved clinical outcomes. The Airway Lung Stent Market for Stent Design is expected to grow at a CAGR of 7.5% from 2024 to 2032, reaching a market value of USD 29.6 billion by 2032.

### **Airway Lung Stent Market Stent Function Insights**

The Airway Lung Stent Market is segmented by Stent Function into Bronchial Stent, Tracheal Stent, and Esophageal Stent. Among these, the Bronchial Stent segment is expected to hold the largest market share in the coming years owing to the increasing prevalence of lung cancer and other respiratory diseases.

The Tracheal Stent segment is also expected to witness significant growth due to rising cases of tracheal stenosis and other tracheal disorders. The [Esophageal Stent](../../../reports/esophageal-stents-market-27185) segment is projected to have a steady growth rate over the forecast period due to the rising incidence of esophageal cancer and other esophageal diseases.

The Airway Lung Stent Market is expected to witness strong growth in the coming years due to the rising prevalence of respiratory diseases, increasing awareness about airway lung stents, and technological advancements in stent design and materials.

### **Airway Lung Stent Market Delivery Method Insights**

The Airway Lung Stent Market is segmented based on delivery method into rigid bronchoscopy, flexible bronchoscopy, and tracheostomy. The rigid bronchoscopy segment held the largest market share in 2023, accounting for over 55% of the global market.

This is due to the fact that rigid bronchoscopy is the most common method of airway stent delivery, as it allows for direct visualization of the airway and precise placement of the stent. The flexible bronchoscopy segment is expected to grow at the highest CAGR over the forecast period, as it is a less invasive procedure than rigid [bronchoscopy](../../../reports/bronchoscopy-market-11508) and can be performed in an outpatient setting.

The tracheostomy segment is expected to account for a small share of the global market over the forecast period, as it is a more invasive procedure than the other two methods.

### **Airway Lung Stent Market Regional Insights**

The Airway Lung Stent Market is segmented into North America, Europe, APAC, South America, and MEA. North America held the largest market share in 2023, accounting for over 40% of the global revenue. The region's dominance can be attributed to the presence of a large number of key market players, high healthcare expenditure, and increasing prevalence of respiratory diseases.

Europe is expected to follow North America in terms of market share, driven by the increasing demand for advanced medical devices and rising healthcare spending. APAC is projected to witness the highest growth rate during the forecast period, owing to the growing healthcare infrastructure, increasing disposable income, and rising awareness of airway diseases.

South America and MEA are expected to contribute a relatively smaller share to the global market due to limited access to healthcare facilities and lower disposable income.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Airway Lung Stent Market Key Players and Competitive Insights:**

Major players in the Airway Lung Stent Market are continuously striving to develop new and innovative products and are also focusing on expanding their global footprints. Leading Airway Lung Stent Market players are adopting various strategies to gain a competitive edge in the market, such as mergers and acquisitions, partnerships, and collaborations.

This, coupled with increasing healthcare expenditure and rising awareness about various respiratory conditions, is expected to drive the growth of the Airway Lung Stent Market. Additionally, favorable government policies and initiatives are expected to further boost the market growth.

Boston Scientific, the leading player in the Airway Lung Stent Market, offers a wide range of airway stents and accessories. The company has a strong global presence and a well-established distribution network.

Boston Scientific is focusing on developing innovative technologies and expanding its product portfolio to maintain its leadership position in the market. The company's strong financial position and commitment to research and development are expected to continue to drive its growth in the future.

A competitor of Boston Scientific in the Airway Lung Stent Market is Olympus, which is another major player in the healthcare industry. Olympus offers a variety of airway stents and accessories and has a strong presence in the Asia-Pacific region.

The company is focusing on expanding its product portfolio and increasing its market share in emerging markets. Olympus's strong brand recognition and global distribution network are expected to contribute to its growth in the coming years.

### **Key Companies in the Airway Lung Stent Market Include:**

- Terumo Corporation
- Smiths Medical
- [Medtronic](https://www.medtronic.com/in-en/patients/treatments-therapies/airway-lung.html)
- Stryker
- BD
- Johnson Johnson
- Vygon
- Cook Medical
- Meril Life Sciences Pvt. Ltd
- Olympus Corporation
- Aesculap
- Braun Melsungen AG
- ConMed Corporation
- Teleflex Incorporated
- [Boston Scientific Corporation](https://www.bostonscientific.com/en-US/products/stents--pulmonary.html)

## **Airway Lung Stent Market Industry Developments**

- **Q2 2024: Boston Scientific Announces FDA Approval of the Ultraflex Airway Stent System** Boston Scientific received FDA approval for its Ultraflex Airway Stent System, designed to treat patients with airway obstructions due to malignant or benign conditions. The approval marks a significant regulatory milestone for the company in the airway stent sector.
- **Q1 2024: Cook Medical Launches New Silicone Airway Stent for Tracheobronchial Obstructions** Cook Medical announced the commercial launch of its new silicone airway stent, expanding its portfolio for the management of tracheobronchial obstructions. The product is now available in select markets following CE mark clearance.
- **Q2 2024: Pulmonx Receives CE Mark for Zephyr Endobronchial Valve for Airway Management** Pulmonx Corporation received CE Mark approval for its Zephyr Endobronchial Valve, enabling expanded use in airway management across Europe. The regulatory clearance supports the company's growth in the lung stent market.
- **Q2 2024: Micro-Tech Endoscopy Announces Partnership with Medtronic for Airway Stent Distribution** Micro-Tech Endoscopy entered into a strategic partnership with Medtronic to distribute its airway stent products in North America, aiming to increase market penetration and improve patient access to advanced airway management solutions.
- **Q3 2024: Olympus Launches New Metal Airway Stent in Japan** Olympus Corporation announced the launch of a new metal airway stent for the Japanese market, targeting patients with malignant airway obstructions. The product launch strengthens Olympus's position in the Asia-Pacific airway stent sector.
- **Q2 2024: FDA Grants Breakthrough Device Designation to Syntheon’s Drug-Eluting Airway Stent** Syntheon received Breakthrough Device Designation from the FDA for its drug-eluting airway stent, which is designed to reduce inflammation and restenosis in patients with airway blockages. The designation accelerates the regulatory review process.
- **Q1 2025: Boston Scientific Acquires Airway Innovations for $120 Million** Boston Scientific completed the acquisition of Airway Innovations, a company specializing in next-generation lung stent technologies, for $120 million. The deal expands Boston Scientific’s product portfolio in the airway stent market.
- **Q2 2025: Cook Medical Opens New Manufacturing Facility for Airway Stents in Ireland** Cook Medical inaugurated a new manufacturing facility in Ireland dedicated to the production of airway stents, aiming to meet growing global demand and improve supply chain efficiency.
- **Q1 2024: Pulmonx Raises $50 Million in Series C Funding to Expand Airway Stent R&D** Pulmonx Corporation secured $50 million in Series C funding to accelerate research and development of its airway stent technologies and support global commercialization efforts.
- **Q3 2024: Olympus Announces Appointment of Dr. Yuki Tanaka as Head of Airway Stent Division** Olympus Corporation appointed Dr. Yuki Tanaka as the new Head of its Airway Stent Division, strengthening its leadership team to drive innovation and growth in the airway stent market.
- **Q2 2025: Micro-Tech Endoscopy Receives FDA Clearance for Next-Generation Self-Expandable Airway Stent** Micro-Tech Endoscopy received FDA clearance for its next-generation self-expandable airway stent, designed to improve patient outcomes in the treatment of airway obstructions.
- **Q1 2025: Syntheon Announces Strategic Partnership with Mayo Clinic for Clinical Trials of Drug-Eluting Airway Stent** Syntheon entered into a strategic partnership with Mayo Clinic to conduct clinical trials for its drug-eluting airway stent, aiming to validate safety and efficacy in patients with complex airway conditions.

## **Airway Lung Stent Market Segmentation Insights**

### **Airway Lung Stent Market Stent Material Outlook**

- Nitinol
- Silicone
- Polyurethane
- Polytetrafluoroethylene (PTFE)
- Stainless Steel

### **Airway Lung Stent Market Stent Design Outlook**

- Single-Flanged Stents
- Double-Flanged Stents
- Palmaz-Schatz Stents
- Wallstents
- Cavitron Ultra Stents

### **Airway Lung Stent Market Stent Function Outlook**

- Bronchial Stent
- Tracheal Stent
- Esophageal Stent

### **Airway Lung Stent Market Delivery Method Outlook**

- Rigid Bronchoscopy
- Flexible Bronchoscopy
- Tracheostomy

### **Airway Lung Stent Market Regional Outlook**

- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa

## Market Drivers

### 增加医疗支出

全球医疗支出不断上升，积极影响全球气道肺支架市场行业。各国政府和私营部门在医疗基础设施和先进医疗技术方面的投资不断增加，其中包括气道支架。这一资金的增加促进了对创新治疗的更好获取，并提升了整体护理质量。随着医疗系统的发展和对呼吸健康的重视，预计市场将在2025年至2035年间以5.44%的年均增长率增长，反映出改善患者结果和扩展治疗选择的承诺。

### 市场增长预测

全球气道肺支架市场预计在未来十年将经历强劲增长。预计到2024年市场价值将达到58.4亿美元，到2035年将达到105亿美元，该行业正处于扩张之中。从2025年到2035年，预计年均增长率为5.44%，这表明气道支架的需求强劲，受到技术进步、呼吸系统疾病流行率上升和人口老龄化等多种因素的推动。这些预测突显了市场的潜力以及在气道管理解决方案中持续投资的重要性。

### 老年人口增长

人口老龄化的趋势是全球气道肺支架市场行业的重要驱动因素。老年人更容易受到呼吸系统疾病的影响，因此需要进行气道支架等干预措施。预计到2050年，全球65岁及以上的人口将翻一番，气道支架的需求也可能相应增加。这一人口趋势凸显了开发有效气道管理解决方案以满足这一脆弱人群需求的重要性，从而促进未来几年的市场增长。

### 监管支持与批准

监管机构在塑造全球气道肺支架市场行业中发挥着关键作用，通过简化新支架技术的审批流程。旨在加快创新医疗设备审查的举措鼓励制造商投资于研发。这种监管支持不仅促进了创新，还确保患者能够及时获得有效的气道管理解决方案。因此，市场可能会见证加速增长，推动这一增长的是符合监管标准并满足临床需求的新产品的推出。

### 支架设计中的技术进步

支架技术的创新正在显著影响全球气道肺支架市场行业。最近的进展包括可生物降解支架和具有增强生物相容性的支架的开发，这些支架减少了并发症并改善了患者的治疗效果。这些创新不仅提高了气道管理的有效性，还扩展了支架在各种临床场景中的应用范围。随着医疗服务提供者越来越多地采用这些先进技术，市场有望实现显著增长，预计到2035年将达到105亿美元，推动因素包括改善的患者护理和手术成功率。

### 呼吸系统疾病发病率上升

全球气道肺支架市场正在增长，原因是呼吸系统疾病（如慢性阻塞性肺病和肺癌）的发病率不断上升。根据健康统计数据，呼吸系统疾病是全球发病率和死亡率的主要原因之一。预计这一趋势将推动气道支架的需求，因为气道支架对于管理气道阻塞至关重要。随着人口老龄化和环境因素导致的呼吸问题，市场预计将在2024年达到58.4亿美元，突显出对有效治疗方案的迫切需求。

## Future Outlook

气道肺支架市场预计将在2024年至2034年间以5.44%的年均增长率增长，推动因素包括技术进步、呼吸系统疾病的日益普遍以及对微创手术的需求上升。

**New opportunities:**

- 开发创新的支架材料，以增强生物相容性并减少并发症。
- 在新兴市场扩大分销网络，以捕捉未开发的客户群体。
- 投资于智能支架技术的研发，使其与数字健康解决方案集成。

到2035年，气道肺支架市场预计将实现显著增长，反映出不断变化的医疗需求和技术进步。

## Segment Insights

### 气道肺支架市场支架材料洞察

气道肺支架市场根据支架材料分为镍钛合金、硅胶、聚氨酯、聚四氟乙烯（PTFE）和不锈钢。其中，镍钛合金因其优越的生物相容性、柔韧性和形状记忆等特性而占据最大的市场份额。

镍钛合金支架通常用于治疗气管支气管狭窄和气道狭窄。硅胶支架是气道肺支架市场中另一种广泛使用的材料。它们具有灵活性、生物相容性和抗结垢等优点。

硅胶支架通常被优先用于长期气道通畅的维护。聚氨酯支架因其生物相容性、柔韧性和放射不透明性而越来越受欢迎。它们通常用于治疗气管支气管恶性肿瘤和气道瘘管。

聚四氟乙烯（PTFE）支架以其高强度、耐用性和抗弯曲性而著称。它们通常用于治疗复杂的气道狭窄和气管支气管瘘。不锈钢支架主要用于治疗气管支气管恶性肿瘤和气道瘘。

它们具有高强度、耐用性和耐腐蚀性等优点。然而，由于不锈钢支架的刚性，可能会导致气道刺激和不适。

### 气道肺支架市场支架设计洞察

气道肺支架市场按支架设计分为单法兰支架、双法兰支架、Palmaz-Schatz支架、Wallstents和Cavitron Ultra支架。其中，单法兰支架在2023年占据了38.4%的最大市场份额，并预计在预测期内将继续保持其主导地位。

这一细分市场的增长可归因于慢性阻塞性肺病（COPD）和哮喘等肺部疾病的日益普遍，这些疾病需要气道支架以有效治疗。双法兰支架在2023年占据了29.5%的显著市场份额，因其能够提供更好的径向支撑并防止支架移位。

Palmaz-Schatz 支架预计在预测期内将保持稳定的增长率，因为它们在治疗复杂气道病变方面的有效性。

Wallstents 和 Cavitron Ultra Stents 是相对较新的技术，因其先进的特性和改善的临床结果而日益受到欢迎。预计气道肺支架市场的支架设计将在 2024 年至 2032 年间以 7.5% 的年均增长率增长，到 2032 年市场价值将达到 296 亿美元。

### 气道肺支架市场支架功能洞察

气道肺支架市场按支架功能分为支气管支架、气管支架和食管支架。在这些支架中，支气管支架细分预计将在未来几年占据最大的市场份额，这主要是由于肺癌和其他呼吸系统疾病的发病率不断增加。

气管支架细分市场预计将因气管狭窄和其他气管疾病病例的增加而显著增长。食管支架细分市场预计在预测期内将保持稳定的增长率，原因是食管癌和其他食管疾病的发病率上升。

气道肺支架市场预计将在未来几年内实现强劲增长，原因是呼吸系统疾病的发病率上升、对气道肺支架的认识提高以及支架设计和材料的技术进步。

### 气道肺支架市场交付方式洞察

气道肺支架市场根据投递方式分为刚性支气管镜、柔性支气管镜和气管切开术。刚性支气管镜细分在2023年占据了最大的市场份额，超过55%的全球市场。

这主要是因为刚性支气管镜是气道支架输送最常用的方法，因为它允许对气道进行直接可视化并精确放置支架。预计在预测期内，柔性支气管镜部分将以最高的复合年增长率增长，因为它是一种比刚性支气管镜更少侵入性的程序，并且可以在门诊环境中进行。

气管切开术在预测期内预计将占全球市场的一小部分，因为它是一种比其他两种方法更具侵入性的程序。

## Regional Market Share Analysis

气道肺支架市场分为北美、欧洲、亚太、南美和中东及非洲。2023年，北美占据了最大的市场份额，超过全球收入的40%。该地区的主导地位可归因于众多主要市场参与者的存在、高额的医疗支出以及呼吸系统疾病的日益普遍。

预计欧洲将在市场份额上紧随北美，推动因素包括对先进医疗设备的需求增加和医疗支出的上升。亚太地区预计在预测期内将见证最高的增长率，这得益于医疗基础设施的不断发展、可支配收入的增加以及对气道疾病的认识提高。

由于医疗设施的有限获取和较低的可支配收入，南美和中东及非洲预计将对全球市场贡献相对较小的份额。

来源：初级研究，次级研究，_市场研究未来_数据库和分析师评审

## Competitive Benchmarking

气道肺支架市场的主要参与者不断努力开发新颖和创新的产品，并专注于扩大其全球足迹。领先的气道肺支架市场参与者正在采取各种策略以在市场中获得竞争优势，例如并购、合作伙伴关系和协作。

此外，随着医疗保健支出的增加和对各种呼吸系统疾病的认识提高，预计将推动气道肺支架市场的增长。此外，政府的有利政策和举措预计将进一步促进市场增长。

波士顿科学公司是气道肺支架市场的领先参与者，提供广泛的气道支架和配件。该公司在全球范围内具有强大的存在感和完善的分销网络。

波士顿科学公司专注于开发创新技术和扩展其产品组合，以保持其在市场中的领导地位。该公司强大的财务状况和对研发的承诺预计将继续推动其未来的增长。

波士顿科学公司的竞争对手是奥林巴斯，后者是医疗保健行业的另一主要参与者。奥林巴斯提供多种气道支架和配件，并在亚太地区具有强大的市场存在。

该公司专注于扩展其产品组合并增加其在新兴市场的市场份额。奥林巴斯强大的品牌认知度和全球分销网络预计将有助于其在未来几年的增长。

## Recent News & Developments

- **2024年第二季度：波士顿科学公司宣布超柔性气道支架系统获得FDA批准** 波士顿科学公司获得FDA批准，其超柔性气道支架系统旨在治疗因恶性或良性病症导致的气道阻塞患者。该批准标志着公司在气道支架领域的重要监管里程碑。
- **2024年第一季度：库克医疗推出新型硅胶气道支架以应对气管支气管阻塞** 库克医疗宣布其新型硅胶气道支架的商业推出，扩展其在气管支气管阻塞管理方面的产品组合。该产品在获得CE标志后现已在部分市场上市。
- **2024年第二季度：Pulmonx获得Zephyr支气管阀的CE标志以进行气道管理** Pulmonx公司获得其Zephyr支气管阀的CE标志批准，使其在欧洲的气道管理中得以扩展使用。该监管许可支持公司在肺支架市场的增长。
- **2024年第二季度：Micro-Tech内窥镜公司宣布与美敦力建立气道支架分销合作伙伴关系** Micro-Tech内窥镜公司与美敦力建立战略合作伙伴关系，以在北美分销其气道支架产品，旨在提高市场渗透率并改善患者对先进气道管理解决方案的获取。
- **2024年第三季度：奥林巴斯在日本推出新型金属气道支架** 奥林巴斯公司宣布在日本市场推出新型金属气道支架，针对恶性气道阻塞患者。该产品的推出巩固了奥林巴斯在亚太地区气道支架领域的地位。
- **2024年第二季度：FDA授予Syntheon的药物洗脱气道支架突破性设备认证** Syntheon获得FDA授予的突破性设备认证，其药物洗脱气道支架旨在减少气道阻塞患者的炎症和再狭窄。该认证加速了监管审查过程。
- **2025年第一季度：波士顿科学以1.2亿美元收购气道创新公司** 波士顿科学完成对气道创新公司的收购，该公司专注于下一代肺支架技术，收购金额为1.2亿美元。此交易扩展了波士顿科学在气道支架市场的产品组合。
- **2025年第二季度：库克医疗在爱尔兰开设新的气道支架制造设施** 库克医疗在爱尔兰启用了一座新的气道支架制造设施，旨在满足日益增长的全球需求并提高供应链效率。
- **2024年第一季度：Pulmonx获得5000万美元C轮融资以扩展气道支架研发** Pulmonx公司获得5000万美元的C轮融资，以加速其气道支架技术的研发并支持全球商业化努力。
- **2024年第三季度：奥林巴斯宣布任命田中幸博士为气道支架部门负责人** 奥林巴斯公司任命田中幸博士为其气道支架部门的新负责人，增强其领导团队以推动气道支架市场的创新和增长。
- **2025年第二季度：Micro-Tech内窥镜公司获得FDA对下一代自扩张气道支架的批准** Micro-Tech内窥镜公司获得FDA对其下一代自扩张气道支架的批准，旨在改善气道阻塞患者的治疗效果。
- **2025年第一季度：Syntheon与梅奥诊所宣布战略合作进行药物洗脱气道支架的临床试验** Syntheon与梅奥诊所达成战略合作，进行其药物洗脱气道支架的临床试验，旨在验证其在复杂气道病症患者中的安全性和有效性。

## Report Scope

| 报告属性/指标 | 详细信息 |
| --- | --- |
| 2024年市场规模 |    5.84（十亿美元） |
| 2025年市场规模 |    6.16（十亿美元） |
| 2035年市场规模 | 10.46（十亿美元） |
| 复合年增长率（CAGR） | 5.44%（2025 - 2035） |
| 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 历史数据 | 2020 - 2024 |
| 市场预测单位 | 十亿美元 |
| 主要公司简介 | Terumo Corporation, Smiths Medical, Medtronic, Stryker, BD, Johnson Johnson, Vygon, Cook Medical, Meril Life Sciences Pvt. Ltd, Olympus Corporation, Aesculap, B. Braun Melsungen AG, ConMed Corporation, Teleflex Incorporated, Boston Scientific Corporation |
| 覆盖的细分市场 | 支架材料、支架设计、支架功能、输送方式、区域 |
| 主要市场机会 | 1 慢性呼吸疾病的发病率增加 2 气道支架设计的技术进步 3 在肺切除手术中的应用扩展 4 对微创治疗的需求增长 5 发达地区的有利报销政策 |
| 主要市场动态 | 慢性阻塞性肺病（COPD）发病率增加 技术进步 对微创手术的需求上升 老年人口增长 有利的报销政策 |
| 覆盖的国家 | 北美、欧洲、亚太地区、南美、中东和非洲 |

## Frequently Asked Questions

**Q: 气道肺支架市场的预计增长是多少？**
A: 气道肺支架市场预计在2025年至2035年的预测期内，总市场价值将增加104.6亿美元。其驱动因素包括需求趋势、技术进步、监管变化和地理扩展。

**Q: 气道肺支架市场的规模是多少？**
A: 气道肺支架市场规模在2024年估计约为58.4亿美元。预计到2035年，该数字将达到104.6亿美元，涵盖所有地区（美洲、欧洲、亚洲、中东和非洲及其他地区），重点关注其细分市场/服务/分销渠道。

**Q: 气道肺支架市场的CAGR是多少？**
A: 气道肺支架市场预计在2025年至2035年间以5.44%的年均增长率（CAGR）增长。

**Q: 到2035年，气道肺支架市场的价值将是多少？**
A: 气道肺支架市场预计到2035年底将达到104.6亿美元，反映出由使用、技术和全球需求驱动的增长。

**Q: 未来10年气道肺支架市场将如何表现？**
A: 在接下来的10年中，气道肺支架市场预计将从58.4亿美元转变为104.6亿美元，主要受先进技术的采用、人口趋势、监管批准的推动，但在2025年至2035年期间可能会面临一些阻力。

**Q: 2024年气道肺支架市场的市场规模是多少？**
A: 气道肺支架市场在2024年达到了49.8亿美元。

**Q: 2024年哪个地区在气道肺支架市场中占据了最大的市场份额？**
A: 2024年北美在气道肺支架市场中占据了最大的市场份额。

**Q: 2024年哪个应用领域在气道肺支架市场中占据最大份额？**
A: 气管支气管段在2024年占据了气道肺支架市场的最大份额。

**Q: 气道肺支架市场的一些主要竞争者是谁？**
A: 气道肺支架市场的一些主要竞争者包括波士顿科学公司、美敦力和戈尔医疗。

**Q: 推动气道肺支架市场增长的一些关键趋势是什么？**
A: 推动气道肺支架市场增长的一些关键趋势包括呼吸系统疾病的日益普遍、微创手术的日益普及以及支架设计的技术进步。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/airway-lung-stent-market-8861*